Phospho-specific Smad3 signaling

References

• Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60:277 - 300; http://dx.doi.org/10.3322/caac.20073; PMID: 20610543
   PubMed Web of Science ®Google Scholar
• Silberstein GB, Daniel CW. Reversible inhibition of mammary gland growth by transforming growth factor-beta. Science 1987; 237:291 - 3; http://dx.doi.org/10.1126/science.3474783; PMID: 3474783
   PubMed Web of Science ®Google Scholar
• Robinson SD, Silberstein GB, Roberts AB, Flanders KC, Daniel CW. Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development. Development 1991; 113:867 - 78; PMID: 1821856
   PubMed Web of Science ®Google Scholar
• Nguyen AV, Pollard JW. Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution. Development 2000; 127:3107 - 18; PMID: 10862748
   PubMed Web of Science ®Google Scholar
• Gorska AE, Joseph H, Derynck R, Moses HL, Serra R. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice. Cell Growth Differ 1998; 9:229 - 38; PMID: 9543389
   PubMedGoogle Scholar
• Jhappan C, Geiser AG, Kordon EC, Bagheri D, Hennighausen L, Roberts AB, et al. Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J 1993; 12:1835 - 45; PMID: 8491177
   PubMed Web of Science ®Google Scholar
• Daniel CW, Robinson S, Silberstein GB. The role of TGF-beta in patterning and growth of the mammary ductal tree. J Mammary Gland Biol Neoplasia 1996; 1:331 - 41; http://dx.doi.org/10.1007/BF02017389; PMID: 10887507
   PubMed Web of Science ®Google Scholar
• Matsuura I, Denissova NG, Wang G, He D, Long J, Liu F. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 2004; 430:226 - 31; http://dx.doi.org/10.1038/nature02650; PMID: 15241418
   PubMed Web of Science ®Google Scholar
• Cooley A, Zelivianski S, Jeruss JS. Impact of cyclin E overexpression on Smad3 activity in breast cancer cell lines. Cell Cycle 2010; 9:4900 - 7; http://dx.doi.org/10.4161/cc.9.24.14158; PMID: 21150326
   PubMed Web of Science ®Google Scholar
• Zelivianski S, Cooley A, Kall R, Jeruss JS. Cyclin-dependent kinase 4-mediated phosphorylation inhibits Smad3 activity in cyclin D-overexpressing breast cancer cells. Mol Cancer Res 2010; 8:1375 - 87; http://dx.doi.org/10.1158/1541-7786.MCR-09-0537; PMID: 20736297
   PubMed Web of Science ®Google Scholar
• Sekimoto G, Matsuzaki K, Yoshida K, Mori S, Murata M, Seki T, et al. Reversible Smad-dependent signaling between tumor suppression and oncogenesis. Cancer Res 2007; 67:5090 - 6; http://dx.doi.org/10.1158/0008-5472.CAN-06-4629; PMID: 17545585
   PubMed Web of Science ®Google Scholar
• Yue J, Mulder KM. Transforming growth factor-beta signal transduction in epithelial cells. Pharmacol Ther 2001; 91:1 - 34; http://dx.doi.org/10.1016/S0163-7258(01)00143-7; PMID: 11707292
   PubMed Web of Science ®Google Scholar
• Massagué J. TGF-beta signal transduction. Annu Rev Biochem 1998; 67:753 - 91; http://dx.doi.org/10.1146/annurev.biochem.67.1.753; PMID: 9759503
   PubMed Web of Science ®Google Scholar
• Lebrun JJ, Vale WW. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation. Mol Cell Biol 1997; 17:1682 - 91; PMID: 9032295
   PubMed Web of Science ®Google Scholar
• Attisano L, Lee-Hoeflich ST. The Smads. Genome Biol 2001; 2:reviews-3010 - reviews3010.8; http://dx.doi.org/10.1186/gb-2001-2-8-reviews3010
   Google Scholar
• Dennler S, Huet S, Gauthier JM. A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3. Oncogene 1999; 18:1643 - 8; http://dx.doi.org/10.1038/sj.onc.1202729; PMID: 10102636
   PubMed Web of Science ®Google Scholar
• Ross S, Hill CS. How the Smads regulate transcription. Int J Biochem Cell Biol 2008; 40:383 - 408; http://dx.doi.org/10.1016/j.biocel.2007.09.006; PMID: 18061509
   PubMed Web of Science ®Google Scholar
• Kohn EA, Du Z, Sato M, Van Schyndle CM, Welsh MA, Yang YA, et al. A novel approach for the generation of genetically modified mammary epithelial cell cultures yields new insights into TGFβ signaling in the mammary gland. Breast Cancer Res 2010; 12:R83; http://dx.doi.org/10.1186/bcr2728; PMID: 20942910
   PubMed Web of Science ®Google Scholar
• Dzwonek J, Preobrazhenska O, Cazzola S, Conidi A, Schellens A, van Dinther M, et al. Smad3 is a key nonredundant mediator of transforming growth factor beta signaling in Nme mouse mammary epithelial cells. Mol Cancer Res 2009; 7:1342 - 53; http://dx.doi.org/10.1158/1541-7786.MCR-08-0558; PMID: 19671686
   PubMed Web of Science ®Google Scholar
• Chen CR, Kang Y, Siegel PM, Massagué J. E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression. Cell 2002; 110:19 - 32; http://dx.doi.org/10.1016/S0092-8674(02)00801-2; PMID: 12150994
   PubMed Web of Science ®Google Scholar
• Feng XH, Liang YY, Liang M, Zhai W, Lin X. Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B). Mol Cell 2002; 9:133 - 43; http://dx.doi.org/10.1016/S1097-2765(01)00430-0; PMID: 11804592
   PubMed Web of Science ®Google Scholar
• Pardali K, Kurisaki A, Morén A, ten Dijke P, Kardassis D, Moustakas A. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. J Biol Chem 2000; 275:29244 - 56; http://dx.doi.org/10.1074/jbc.M909467199; PMID: 10878024
   PubMed Web of Science ®Google Scholar
• Sandhu C, Garbe J, Bhattacharya N, Daksis J, Pan CH, Yaswen P, et al. Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells. Mol Cell Biol 1997; 17:2458 - 67; PMID: 9111314
   PubMed Web of Science ®Google Scholar
• Reynisdóttir I, Polyak K, Iavarone A, Massagué J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev 1995; 9:1831 - 45; http://dx.doi.org/10.1101/gad.9.15.1831; PMID: 7649471
   PubMed Web of Science ®Google Scholar
• Moustakas A, Pardali K, Gaal A, Heldin CH. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol Lett 2002; 82:85 - 91; http://dx.doi.org/10.1016/S0165-2478(02)00023-8; PMID: 12008039
   PubMed Web of Science ®Google Scholar
• Iavarone A, Massagué J. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15. Nature 1997; 387:417 - 22; http://dx.doi.org/10.1038/387417a0; PMID: 9163429
   PubMed Web of Science ®Google Scholar
• Jeruss JS, Sturgis CD, Rademaker AW, Woodruff TK. Down-regulation of activin, activin receptors, and Smads in high-grade breast cancer. Cancer Res 2003; 63:3783 - 90; PMID: 12839974
   PubMed Web of Science ®Google Scholar
• Kretzschmar M, Doody J, Timokhina I, Massagué J. A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. Genes Dev 1999; 13:804 - 16; http://dx.doi.org/10.1101/gad.13.7.804; PMID: 10197981
   PubMed Web of Science ®Google Scholar
• Mori S, Matsuzaki K, Yoshida K, Furukawa F, Tahashi Y, Yamagata H, et al. TGF-beta and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions. Oncogene 2004; 23:7416 - 29; http://dx.doi.org/10.1038/sj.onc.1207981; PMID: 15326485
   PubMed Web of Science ®Google Scholar
• Furukawa F, Matsuzaki K, Mori S, Tahashi Y, Yoshida K, Sugano Y, et al. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. Hepatology 2003; 38:879 - 89; PMID: 14512875
   PubMed Web of Science ®Google Scholar
• Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, et al. Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993; 8:2127 - 33; PMID: 8336939
   PubMed Web of Science ®Google Scholar
• Hall M, Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 1996; 68:67 - 108; http://dx.doi.org/10.1016/S0065-230X(08)60352-8; PMID: 8712071
   PubMed Web of Science ®Google Scholar
• Lin DI, Lessie MD, Gladden AB, Bassing CH, Wagner KU, Diehl JA. Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis. Oncogene 2008; 27:1231 - 42; http://dx.doi.org/10.1038/sj.onc.1210738; PMID: 17724472
   PubMed Web of Science ®Google Scholar
• Kim JK, Diehl JA. Nuclear cyclin D1: an oncogenic driver in human cancer. J Cell Physiol 2009; 220:292 - 6; http://dx.doi.org/10.1002/jcp.21791; PMID: 19415697
   PubMed Web of Science ®Google Scholar
• Satyanarayana A, Kaldis P. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 2009; 28:2925 - 39; http://dx.doi.org/10.1038/onc.2009.170; PMID: 19561645
   PubMed Web of Science ®Google Scholar
• Boström P, Söderström M, Palokangas T, Vahlberg T, Collan Y, Carpen O, et al. Analysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factors. BMC Res Notes 2009; 2:140; http://dx.doi.org/10.1186/1756-0500-2-140; PMID: 19615042
   PubMedGoogle Scholar
• Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, et al. Cyclin E and survival in patients with breast cancer. N Engl J Med 2002; 347:1566 - 75; http://dx.doi.org/10.1056/NEJMoa021153; PMID: 12432043
   PubMed Web of Science ®Google Scholar
• Fadare O, Tavassoli FA. Clinical and pathologic aspects of basal-like breast cancers. Nat Clin Pract Oncol 2008; 5:149 - 59; http://dx.doi.org/10.1038/ncponc1038; PMID: 18212769
   PubMedGoogle Scholar
• Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000; 406:747 - 52; http://dx.doi.org/10.1038/35021093; PMID: 10963602
   PubMed Web of Science ®Google Scholar
• Matsuzaki K, Kitano C, Murata M, Sekimoto G, Yoshida K, Uemura Y, et al. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer. Cancer Res 2009; 69:5321 - 30; http://dx.doi.org/10.1158/0008-5472.CAN-08-4203; PMID: 19531654
   PubMed Web of Science ®Google Scholar
• Liu F. Smad3 phosphorylation by cyclin-dependent kinases. Cytokine Growth Factor Rev 2006; 17:9 - 17; http://dx.doi.org/10.1016/j.cytogfr.2005.09.010; PMID: 16289004
   PubMed Web of Science ®Google Scholar
• Matsuzaki K. Smad phosphoisoform signaling specificity: the right place at the right time. Carcinogenesis 2011; 32:1578 - 88; http://dx.doi.org/10.1093/carcin/bgr172; PMID: 21798854
   PubMed Web of Science ®Google Scholar
• Bos JL. ras oncogenes in human cancer: a review. Cancer Res 1989; 49:4682 - 9; PMID: 2547513
   PubMed Web of Science ®Google Scholar
• von Lintig FC, Dreilinger AD, Varki NM, Wallace AM, Casteel DE, Boss GR. Ras activation in human breast cancer. Breast Cancer Res Treat 2000; 62:51 - 62; http://dx.doi.org/10.1023/A:1006491619920; PMID: 10989985
   PubMed Web of Science ®Google Scholar
• Matsuzaki K. Modulation of TGF-beta signaling during progression of chronic liver diseases. Front Biosci 2009; 14:2923 - 34; http://dx.doi.org/10.2741/3423; PMID: 19273245
   PubMed Web of Science ®Google Scholar
• Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80:179 - 85; http://dx.doi.org/10.1016/0092-8674(95)90401-8; PMID: 7834738
   PubMed Web of Science ®Google Scholar
• Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001; 410:37 - 40; http://dx.doi.org/10.1038/35065000; PMID: 11242034
   PubMed Web of Science ®Google Scholar
• Dobrowolski S, Harter M, Stacey DW. Cellular ras activity is required for passage through multiple points of the G0/G1 phase in BALB/c 3T3 cells. Mol Cell Biol 1994; 14:5441 - 9; PMID: 8035821
   PubMed Web of Science ®Google Scholar
• Mulcahy LS, Smith MR, Stacey DW. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 1985; 313:241 - 3; http://dx.doi.org/10.1038/313241a0; PMID: 3918269
   PubMed Web of Science ®Google Scholar
• Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A, et al. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 1995; 270:23589 - 97; http://dx.doi.org/10.1074/jbc.270.40.23589; PMID: 7559524
   PubMed Web of Science ®Google Scholar
• Arber N, Sutter T, Miyake M, Kahn SM, Venkatraj VS, Sobrino A, et al. Increased expression of cyclin D1 and the Rb tumor suppressor gene in c-K-ras transformed rat enterocytes. Oncogene 1996; 12:1903 - 8; PMID: 8649851
   PubMed Web of Science ®Google Scholar
• Liu JJ, Chao JR, Jiang MC, Ng SY, Yen JJ, Yang-Yen HF. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol Cell Biol 1995; 15:3654 - 63; PMID: 7791772
   PubMed Web of Science ®Google Scholar
• Winston JT, Coats SR, Wang YZ, Pledger WJ. Regulation of the cell cycle machinery by oncogenic ras. Oncogene 1996; 12:127 - 34; PMID: 8552383
   PubMed Web of Science ®Google Scholar
• Matsushime H, Roussel MF, Ashmun RA, Sherr CJ. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 1991; 65:701 - 13; http://dx.doi.org/10.1016/0092-8674(91)90101-4; PMID: 1827757
   PubMed Web of Science ®Google Scholar
• Yu Q, Geng Y, Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature 2001; 411:1017 - 21; http://dx.doi.org/10.1038/35082500; PMID: 11429595
   PubMed Web of Science ®Google Scholar
• Liu F, Matsuura I. Inhibition of Smad antiproliferative function by CDK phosphorylation. Cell Cycle 2005; 4:63 - 6; http://dx.doi.org/10.4161/cc.4.1.1366; PMID: 15611645
   PubMed Web of Science ®Google Scholar
• Lee EK, Diehl JA. Breast cancer go sMAD: cyclin towards aggressive phenotypes. Cell Cycle 2011; 10:187; http://dx.doi.org/10.4161/cc.10.2.14480; PMID: 21239879
   PubMed Web of Science ®Google Scholar
• Ikushima H, Miyazono K. TGF-β signal transduction spreading to a wider field: a broad variety of mechanisms for context-dependent effects of TGF-β. Cell Tissue Res 2012; 347:37 - 49; http://dx.doi.org/10.1007/s00441-011-1179-5; PMID: 21618142
   PubMed Web of Science ®Google Scholar
• Heldin CH, Moustakas A. Role of Smads in TGFβ signaling. Cell Tissue Res 2012; 347:21 - 36; http://dx.doi.org/10.1007/s00441-011-1190-x; PMID: 21643690
   PubMed Web of Science ®Google Scholar
• Sundqvist A, Ten Dijke P, van Dam H. Key signaling nodes in mammary gland development and cancer: Smad signal integration in epithelial cell plasticity. Breast Cancer Res 2012; 14:204; http://dx.doi.org/10.1186/bcr3066; PMID: 22315972
   PubMed Web of Science ®Google Scholar
• Gao S, Alarcón C, Sapkota G, Rahman S, Chen PY, Goerner N, et al. Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling. Mol Cell 2009; 36:457 - 68; http://dx.doi.org/10.1016/j.molcel.2009.09.043; PMID: 19917253
   PubMed Web of Science ®Google Scholar
• Lin X, Duan X, Liang YY, Su Y, Wrighton KH, Long J, et al. PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Cell 2006; 125:915 - 28; http://dx.doi.org/10.1016/j.cell.2006.03.044; PMID: 16751101
   PubMed Web of Science ®Google Scholar
• Sapkota G, Knockaert M, Alarcón C, Montalvo E, Brivanlou AH, Massagué J. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways. J Biol Chem 2006; 281:40412 - 9; http://dx.doi.org/10.1074/jbc.M610172200; PMID: 17085434
   PubMed Web of Science ®Google Scholar
• Wrighton KH, Willis D, Long J, Liu F, Lin X, Feng XH. Small C-terminal domain phosphatases dephosphorylate the regulatory linker regions of Smad2 and Smad3 to enhance transforming growth factor-beta signaling. J Biol Chem 2006; 281:38365 - 75; http://dx.doi.org/10.1074/jbc.M607246200; PMID: 17035229
   PubMed Web of Science ®Google Scholar
• Kang JM, Park S, Kim SJ, Hong HY, Jeong J, Kim HS, et al. CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling. Oncogene 2012; http://dx.doi.org/10.1038/onc.2012.18; PMID: 22310290
   PubMed Web of Science ®Google Scholar
• Lin Q, Chen D, Timchenko NA, Medrano EE. SKI promotes Smad3 linker phosphorylations associated with the tumor-promoting trait of TGFbeta. Cell Cycle 2010; 9:1684 - 9; http://dx.doi.org/10.4161/cc.9.9.11292; PMID: 20404506
   PubMed Web of Science ®Google Scholar
• Theohari I, Giannopoulou I, Magkou C, Nomikos A, Melissaris S, Nakopoulou L. Differential effect of the expression of TGF-β pathway inhibitors, Smad-7 and Ski, on invasive breast carcinomas: relation to biologic behavior. APMIS 2012; 120:92 - 100; http://dx.doi.org/10.1111/j.1600-0463.2011.02814.x; PMID: 22229264
   PubMed Web of Science ®Google Scholar
• Wulf GM, Ryo A, Wulf GG, Lee SW, Niu T, Petkova V, et al. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J 2001; 20:3459 - 72; http://dx.doi.org/10.1093/emboj/20.13.3459; PMID: 11432833
   PubMed Web of Science ®Google Scholar
• Wulf G, Ryo A, Liou YC, Lu KP. The prolyl isomerase Pin1 in breast development and cancer. Breast Cancer Res 2003; 5:76 - 82; http://dx.doi.org/10.1186/bcr572; PMID: 12631385
   PubMed Web of Science ®Google Scholar
• Matsuura I, Chiang KN, Lai CY, He D, Wang G, Ramkumar R, et al. Pin1 promotes transforming growth factor-beta-induced migration and invasion. J Biol Chem 2010; 285:1754 - 64; http://dx.doi.org/10.1074/jbc.M109.063826; PMID: 19920136
   PubMed Web of Science ®Google Scholar
• Fuxe J, Vincent T, Garcia de Herreros A. Transcriptional crosstalk between TGF-β and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle 2010; 9:2363 - 74; http://dx.doi.org/10.4161/cc.9.12.12050; PMID: 20519943
   PubMed Web of Science ®Google Scholar
• Moustakas A, Heldin CH. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 2007; 98:1512 - 20; http://dx.doi.org/10.1111/j.1349-7006.2007.00550.x; PMID: 17645776
   PubMed Web of Science ®Google Scholar
• Nawshad A, Lagamba D, Polad A, Hay ED. Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs 2005; 179:11 - 23; http://dx.doi.org/10.1159/000084505; PMID: 15942189
   PubMed Web of Science ®Google Scholar
• Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 1995; 154:8 - 20; http://dx.doi.org/10.1159/000147748; PMID: 8714286
   PubMedGoogle Scholar
• Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, Kah KJ, et al. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 2011; 145:926 - 40; http://dx.doi.org/10.1016/j.cell.2011.04.029; PMID: 21663795
   PubMed Web of Science ®Google Scholar
• Teicher BA. Malignant cells, directors of the malignant process: role of transforming growth factor-beta. Cancer Metastasis Rev 2001; 20:133 - 43; http://dx.doi.org/10.1023/A:1013177011767; PMID: 11831642
   PubMed Web of Science ®Google Scholar
• Matsuzaki K, Murata M, Yoshida K, Sekimoto G, Uemura Y, Sakaida N, et al. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology 2007; 46:48 - 57; http://dx.doi.org/10.1002/hep.21672; PMID: 17596875
   PubMed Web of Science ®Google Scholar
• Murata M, Matsuzaki K, Yoshida K, Sekimoto G, Tahashi Y, Mori S, et al. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. Hepatology 2009; 49:1203 - 17; http://dx.doi.org/10.1002/hep.22765; PMID: 19263472
   PubMed Web of Science ®Google Scholar
• Matsuzaki K, Okazaki K. Transforming growth factor-beta during carcinogenesis: the shift from epithelial to mesenchymal signaling. J Gastroenterol 2006; 41:295 - 303; http://dx.doi.org/10.1007/s00535-006-1795-0; PMID: 16741607
   PubMed Web of Science ®Google Scholar
• Wolfraim LA, Fernandez TM, Mamura M, Fuller WL, Kumar R, Cole DE, et al. Loss of Smad3 in acute T-cell lymphoblastic leukemia. N Engl J Med 2004; 351:552 - 9; http://dx.doi.org/10.1056/NEJMoa031197; PMID: 15295048
   PubMed Web of Science ®Google Scholar
• Ungefroren H, Groth S, Sebens S, Lehnert H, Gieseler F, Fändrich F. Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1. Mol Cancer 2011; 10:67; http://dx.doi.org/10.1186/1476-4598-10-67; PMID: 21624123
   PubMed Web of Science ®Google Scholar
• Bello-DeOcampo D, Tindall DJ. TGF-betal/Smad signaling in prostate cancer. Curr Drug Targets 2003; 4:197 - 207; http://dx.doi.org/10.2174/1389450033491118; PMID: 12643470
   PubMed Web of Science ®Google Scholar
• Tian F, DaCosta Byfield S, Parks WT, Yoo S, Felici A, Tang B, et al. Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res 2003; 63:8284 - 92; PMID: 14678987
   PubMed Web of Science ®Google Scholar
• Kim SH, Ahn S, Park CK. Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy. Hepatobiliary Pancreat Dis Int 2012; 11:51 - 9; http://dx.doi.org/10.1016/S1499-3872(11)60125-2; PMID: 22251470
   PubMed Web of Science ®Google Scholar
• Pennison M, Pasche B. Targeting transforming growth factor-beta signaling. Curr Opin Oncol 2007; 19:579 - 85; http://dx.doi.org/10.1097/CCO.0b013e3282f0ad0e; PMID: 17906455
   PubMed Web of Science ®Google Scholar
• Mullen AC, Orlando DA, Newman JJ, Lovén J, Kumar RM, Bilodeau S, et al. Master transcription factors determine cell-type-specific responses to TGF-β signaling. Cell 2011; 147:565 - 76; http://dx.doi.org/10.1016/j.cell.2011.08.050; PMID: 22036565
   PubMed Web of Science ®Google Scholar